Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken-Hong Lim

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Medical Oncology (Northwood, London, England)|April 9, 2017
Targeted next-generation sequencing identified novel mutations in triple-negative myeloproliferative neoplasmsYu-Cheng Chang, Huan-Chau Lin, Yi-Hao Chiang, et al.
Annals of Hematology|April 26, 2024
Analysis of mutation profiles in extranodal NK/T-cell lymphoma: clinical and prognostic correlationsYu-Cheng Chang, Hui-Jen Tsai, To-Yu Huang, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
Synthesis and evaluation of [18F]Fluorobutyl ethacrynic amide: a potential PET tracer for studying glutathione transferaseHo-Lien Huang, Chun-Nan Yeh, Kang-Wei Chang, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 3, 2014
Rapid and sensitive detection of CALR exon 9 mutations using high-resolution melting analysisKen-Hong Lim, Huan-Chau Lin, Caleb Gon-Shen Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|February 8, 2018
EGFR-mediated interleukin enhancer-binding factor 3 contributes to formation and survival of cancer stem-like tumorspheres as a therapeutic target against EGFR-positive non-small cell lung cancerChun-Chia Cheng, Kuei-Fang Chou, Cheng-Wen Wu, et al.
Oncotarget|November 5, 2017
Germline variations at <i>JAK2</i>, <i>TERT</i>, <i>HBS1L-MYB</i> and <i>MECOM</i> and the risk of myeloproliferative neoplasms in Taiwanese populationYi-Hao Chiang, Yu-Cheng Chang, Huan-Chau Lin, et al.
Oncotarget|April 19, 2017
Increased B cell activation is present in JAK2V617F-mutated, CALR-mutated and triple-negative essential thrombocythemiaKen-Hong Lim, Caleb Gon-Shen Chen, Yu-Cheng Chang, et al.
The Lancet. Haematology|November 5, 2025
Ropeginterferon alfa-2b in hydroxyurea-intolerant or hydroxyurea-refractory essential thrombocythaemia (SURPASS ET): a multicentre, open-label, randomised, active-controlled, phase 3 studyRuben Mesa, Harinder Gill, Lei Zhang, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Medical Oncology (Northwood, London, England)|April 9, 2017
Targeted next-generation sequencing identified novel mutations in triple-negative myeloproliferative neoplasmsYu-Cheng Chang, Huan-Chau Lin, Yi-Hao Chiang, et al.
Annals of Hematology|April 26, 2024
Analysis of mutation profiles in extranodal NK/T-cell lymphoma: clinical and prognostic correlationsYu-Cheng Chang, Hui-Jen Tsai, To-Yu Huang, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
Synthesis and evaluation of [18F]Fluorobutyl ethacrynic amide: a potential PET tracer for studying glutathione transferaseHo-Lien Huang, Chun-Nan Yeh, Kang-Wei Chang, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 3, 2014
Rapid and sensitive detection of CALR exon 9 mutations using high-resolution melting analysisKen-Hong Lim, Huan-Chau Lin, Caleb Gon-Shen Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|February 8, 2018
EGFR-mediated interleukin enhancer-binding factor 3 contributes to formation and survival of cancer stem-like tumorspheres as a therapeutic target against EGFR-positive non-small cell lung cancerChun-Chia Cheng, Kuei-Fang Chou, Cheng-Wen Wu, et al.
Oncotarget|November 5, 2017
Germline variations at <i>JAK2</i>, <i>TERT</i>, <i>HBS1L-MYB</i> and <i>MECOM</i> and the risk of myeloproliferative neoplasms in Taiwanese populationYi-Hao Chiang, Yu-Cheng Chang, Huan-Chau Lin, et al.
Oncotarget|April 19, 2017
Increased B cell activation is present in JAK2V617F-mutated, CALR-mutated and triple-negative essential thrombocythemiaKen-Hong Lim, Caleb Gon-Shen Chen, Yu-Cheng Chang, et al.
The Lancet. Haematology|November 5, 2025
Ropeginterferon alfa-2b in hydroxyurea-intolerant or hydroxyurea-refractory essential thrombocythaemia (SURPASS ET): a multicentre, open-label, randomised, active-controlled, phase 3 studyRuben Mesa, Harinder Gill, Lei Zhang, et al.
Pageof 4